Sale!

GLE1 Gene Lethal Congenital Contracture Syndrome Type 1 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The GLE1 Gene Lethal Congenital Contracture Syndrome Type 1 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the GLE1 gene, which are responsible for causing Lethal Congenital Contracture Syndrome Type 1 (LCCS1). LCCS1 is a severe genetic disorder characterized by congenital contractures of the limbs and fetal akinesia, leading to prenatal death or severe disability. This test is crucial for families with a history of the condition, as it helps in early diagnosis, allowing for informed decisions regarding management and care.

Performed through a detailed analysis of the individual’s DNA, the test seeks to identify specific mutations in the GLE1 gene that are known to cause the syndrome. Given the complexity and the advanced technology required for such genetic testing, the cost of the test is set at 4400 AED. Conducting the test at DNA Labs UAE ensures accuracy and reliability, as the facility is equipped with state-of-the-art technology and staffed by professionals specialized in genetic diagnostics. This test is an invaluable resource for at-risk families, providing them with critical information about their genetic health and helping to guide their future medical and personal decisions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GLE1 Gene Lethal Congenital Contracture Syndrome Type 1 Genetic Test

Components

Price: 4400.0 AED

Sample Condition

Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery

3 to 4 Weeks

Method

NGS Technology

Test Type

Dysmorphology

Doctor

Pediatrics

Test Department

Genetics

Pre Test Information

Clinical History of Patient who is going for GLE1 Gene Lethal Congenital Contracture Syndrome Type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GLE1 Gene Lethal Congenital Contracture Syndrome Type 1 NGS Genetic DNA Test gene GLE1.

Test Details

The GLE1 gene is associated with a condition called lethal congenital contracture syndrome type 1 (LCCS1). LCCS1 is a rare genetic disorder characterized by multiple joint contractures (abnormal shortening of muscles or tendons around joints), weak muscle tone (hypotonia), and respiratory failure, often leading to death shortly after birth.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of LCCS1, NGS genetic testing can be used to identify mutations or variations in the GLE1 gene that may be causing the disorder. This testing can help with confirming a diagnosis, providing information about the specific genetic variant involved, and informing genetic counseling and family planning decisions.

It’s important to note that NGS genetic testing is typically performed in specialized laboratories and requires a healthcare professional’s order. The results of the test should be interpreted by a qualified geneticist or genetic counselor to provide accurate and meaningful information.

Test Name GLE1 Gene Lethal congenital contracture syndrome type 1 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Dysmorphology
Doctor Pediatrics
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for GLE1 Gene Lethal congenital contracture syndrome type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GLE1 Gene Lethal congenital contracture syndrome type 1 NGS Genetic DNA Test gene GLE1
Test Details

The GLE1 gene is associated with a condition called lethal congenital contracture syndrome type 1 (LCCS1). LCCS1 is a rare genetic disorder characterized by multiple joint contractures (abnormal shortening of muscles or tendons around joints), weak muscle tone (hypotonia), and respiratory failure, often leading to death shortly after birth.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of LCCS1, NGS genetic testing can be used to identify mutations or variations in the GLE1 gene that may be causing the disorder. This testing can help with confirming a diagnosis, providing information about the specific genetic variant involved, and informing genetic counseling and family planning decisions.

It’s important to note that NGS genetic testing is typically performed in specialized laboratories and requires a healthcare professional’s order. The results of the test should be interpreted by a qualified geneticist or genetic counselor to provide accurate and meaningful information.